Breast Neoplasms - Exposure Details | CTD
Skip navigation

Disease Breast Neoplasms

These are exposure details associated with the disease and all of its children.



1–50 of 1,180 results.
  Reference Exposure Stressor Number of Receptors Receptors Receptor Notes Medium Exposure Marker Marker Level Measurement Statistic Assay Notes Country Outcome Relationship Disease Phenotype
1. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Veterans Marines exposed to water contamination at Camp Lajeune United States prediction/hypothesis Breast Neoplasms
2. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Controls for disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune 1,2-dichloroethylene 434.53 micrograms per liter concentration United States
3. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Controls for disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune United States prediction/hypothesis Breast Neoplasms
4. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Subjects with disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune United States prediction/hypothesis Breast Neoplasms
5. Ruckart PZ, et al. (2015). 1,2-dichloroethylene 444 Subjects with disease:Breast Neoplasms Marines exposed to water contamination at Camp Lajeune 1,2-dichloroethylene 434.53 micrograms per liter concentration United States
6. Holmes AK, et al. (2014). 2,2',3',4,4',5-hexachlorobiphenyl 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',3',4,4',5-hexachlorobiphenyl 386 nanograms per gram lipid geometric mean PCB-138, PCB-158 United States
7. Holmes AK, et al. (2014). 2,2',3',4,4',5-hexachlorobiphenyl 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum 2,2',3',4,4',5-hexachlorobiphenyl United States no correlation Breast Neoplasms
8. Holmes AK, et al. (2014). 2,2',3',4,4',5-hexachlorobiphenyl 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',3',4,4',5-hexachlorobiphenyl 436 nanograms per gram lipid geometric mean PCB-138, PCB-158 United States
9. Holmes AK, et al. (2014). 2,2',4,4'-tetrabromodiphenyl ether 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',4,4'-tetrabromodiphenyl ether 25.1 nanograms per gram lipid geometric mean United States
10. Holmes AK, et al. (2014). 2,2',4,4'-tetrabromodiphenyl ether 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum 2,2',4,4'-tetrabromodiphenyl ether United States prediction/hypothesis Breast Neoplasms
11. Holmes AK, et al. (2014). 2,2',4,4'-tetrabromodiphenyl ether 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,2',4,4'-tetrabromodiphenyl ether 38.8 nanograms per gram lipid geometric mean United States
12. Holmes AK, et al. (2014). 2,4,5,2',4',5'-hexachlorobiphenyl 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,4,5,2',4',5'-hexachlorobiphenyl 632 nanograms per gram lipid geometric mean United States
13. Holmes AK, et al. (2014). 2,4,5,2',4',5'-hexachlorobiphenyl 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum 2,4,5,2',4',5'-hexachlorobiphenyl United States no correlation Breast Neoplasms
14. Holmes AK, et al. (2014). 2,4,5,2',4',5'-hexachlorobiphenyl 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum 2,4,5,2',4',5'-hexachlorobiphenyl 541 nanograms per gram lipid geometric mean United States
15. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 710 Subjects with disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 196 micrograms per gram creatinine 95th percentile United States
16. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 710 Subjects with disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 37.7 micrograms per gram creatinine median United States
17. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 598 Controls for disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 199 micrograms per gram creatinine 95th percentile United States
18. Parada H JR, et al. (2018). 2-ethyl-5-carboxypentyl phthalate 598 Controls for disease:Breast Neoplasms urine 2-ethyl-5-carboxypentyl phthalate 38.6 micrograms per gram creatinine median United States
19. Wilson KM, et al. (2009). Acrylamide 90,628 Workers Nurses age 25-42 at start of study in 1989 United States no correlation Breast Neoplasms
20. Ranzi A, et al. (2011). Air Pollutants 16,193 Study subjects Metals, Heavy Italy positive correlation Breast Neoplasms
21. Freeman LE, et al. (2011). Atrazine 53,662 Workers Pesticide applicators United States no correlation Breast Neoplasms
22. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,334 Controls for disease:Breast Neoplasms Benzo(a)pyrene 0.55 relative units interquartile range exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
23. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,334 Controls for disease:Breast Neoplasms Benzo(a)pyrene 0.97 relative units mean exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
24. Mordukhovich I, et al. (2015). Benzo(a)pyrene Controls for disease:Breast Neoplasms 566-597 controls Benzo(a)pyrene 196.71 relative units mean mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
25. Mordukhovich I, et al. (2015). Benzo(a)pyrene Subjects with disease:Breast Neoplasms 520-551 cases Benzo(a)pyrene 227.42 relative units mean mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
26. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,274 Subjects with disease:Breast Neoplasms Benzo(a)pyrene 1.03 relative units mean exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
27. Mordukhovich I, et al. (2015). Benzo(a)pyrene 1,274 Subjects with disease:Breast Neoplasms Benzo(a)pyrene 0.62 relative units interquartile range exposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
28. Mordukhovich I, et al. (2015). Benzo(a)pyrene 3,064 Study subjects mix of cases and controls for Breast Neoplasms United States positive correlation Breast Neoplasms
29. Mordukhovich I, et al. (2015). Benzo(a)pyrene Controls for disease:Breast Neoplasms 566-597 controls Benzo(a)pyrene 122.06 relative units interquartile range mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
30. Mordukhovich I, et al. (2015). Benzo(a)pyrene 3,064 Study subjects mix of cases and controls for Breast Neoplasms United States positive correlation Breast Neoplasms
31. Mordukhovich I, et al. (2015). Benzo(a)pyrene Subjects with disease:Breast Neoplasms 520-551 cases Benzo(a)pyrene 125.31 relative units interquartile range mean values for multiple years represent cumulative versus mean annual exposureexposure levels were normalized to average benzo(a)pyrene exposure in 1995 and expressed as relative units United States
32. Holmes AK, et al. (2014). beta-hexachlorocyclohexane 170 Study subjects mix of 75 cases and 95 controls for Breast Neoplasms with Eskimo, Indian and Aleut ethnicities represented serum beta-hexachlorocyclohexane United States no correlation Breast Neoplasms
33. Holmes AK, et al. (2014). beta-hexachlorocyclohexane 75 Subjects with disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum beta-hexachlorocyclohexane 143 nanograms per gram lipid geometric mean United States
34. Holmes AK, et al. (2014). beta-hexachlorocyclohexane 95 Controls for disease:Breast Neoplasms Eskimo, Indian and Aleut ethnicities represented serum beta-hexachlorocyclohexane 158 nanograms per gram lipid geometric mean United States
35. López-Carrillo L, et al. (2010). butylbenzyl phthalate 74 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 7.22 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
36. López-Carrillo L, et al. (2010). butylbenzyl phthalate 187 Subjects with disease:Breast Neoplasms urine butylbenzyl phthalate 0-5.18 micrograms per gram creatinine First tertile C1/b = monobenzyl phthalate Mexico
37. López-Carrillo L, et al. (2010). butylbenzyl phthalate 123 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 10.8-258.62 micrograms per gram creatinine Third tertile C1/b = monobenzyl phthalate Mexico
38. López-Carrillo L, et al. (2010). butylbenzyl phthalate 142 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 5.19-10.79 micrograms per gram creatinine Second tertile C1/b = monobenzyl phthalate Mexico
39. López-Carrillo L, et al. (2010). butylbenzyl phthalate Subjects with disease:Breast Neoplasms urine butylbenzyl phthalate C1/b = monobenzyl phthalate Mexico negative correlation Breast Neoplasms
40. López-Carrillo L, et al. (2010). butylbenzyl phthalate 187 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 0-5.18 micrograms per gram creatinine First tertile C1/b = monobenzyl phthalate Mexico
41. López-Carrillo L, et al. (2010). butylbenzyl phthalate 174 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 5.84 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
42. López-Carrillo L, et al. (2010). butylbenzyl phthalate 221 Controls for disease:Breast Neoplasms urine butylbenzyl phthalate 6.27 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
43. López-Carrillo L, et al. (2010). butylbenzyl phthalate 123 Subjects with disease:Breast Neoplasms urine butylbenzyl phthalate 10.8-258.62 micrograms per gram creatinine Third tertile C1/b = monobenzyl phthalate Mexico
44. López-Carrillo L, et al. (2010). butylbenzyl phthalate 142 Subjects with disease:Breast Neoplasms urine butylbenzyl phthalate 5.19-10.79 micrograms per gram creatinine Second tertile C1/b = monobenzyl phthalate Mexico
45. López-Carrillo L, et al. (2010). butylbenzyl phthalate 145 Subjects with disease:Breast Neoplasms Postmenopausal breast cancer patients urine butylbenzyl phthalate 5.51 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
46. López-Carrillo L, et al. (2010). butylbenzyl phthalate Controls for disease:Breast Neoplasms urine butylbenzyl phthalate C1/b = monobenzyl phthalate Mexico negative correlation Breast Neoplasms
47. López-Carrillo L, et al. (2010). butylbenzyl phthalate 88 Subjects with disease:Breast Neoplasms Premenopausal breast cancer patients urine butylbenzyl phthalate 5.29 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
48. López-Carrillo L, et al. (2010). butylbenzyl phthalate 233 Subjects with disease:Breast Neoplasms urine butylbenzyl phthalate 5.43 micrograms per gram creatinine geometric mean C1/b = monobenzyl phthalate Mexico
49. Gallagher CM, et al. (2010). Cadmium 3,219 Study subjects urine United States positive correlation Breast Neoplasms
50. Satarug S, et al. (2017). Cadmium 2,976 Study subjects mix of 92 cases and 2,884 controls for Breast Neoplasms urine United States positive correlation Breast Neoplasms
1–50 of 1,180 results.